Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

15.40
Delayed Data
As of 3:59pm ET
 -0.60 / -3.75%
Today’s Change
6.91
Today|||52-Week Range
18.00
+65.41%
Year-to-Date
AstraZeneca (AZN) Presents Tagrisso Data at Medical Meeting
10:02am / Zacks.com - Paid Partner Content
Cytori Scleroderma Study Two-Year Follow-Up Data Published
Nov 30 / Zacks.com - Paid Partner Content
Sage Therapeutics Stock Up on SAGE-547 Regulatory Update
9:58am / Zacks.com - Paid Partner Content
PhaseRx Soars on Orphan Drug Status for Rare Liver Disease
Nov 30 / Zacks.com - Paid Partner Content
Theravance Stock Up on Fast Track Status for Velusetrag
9:32am / Zacks.com - Paid Partner Content
Novo Nordisk's Tresiba Shows Safe Cardiovascular Profile
Nov 30 / Zacks.com - Paid Partner Content
Bristol-Myers Reports Data from Opdivo Combination Studies
Dec 06 / Zacks.com - Paid Partner Content
Protalix BioTherapeutics (PLX) Jumps: Stock Rises 14.3%
Nov 30 / Zacks.com - Paid Partner Content
GW Pharma (GWPH) Posts Narrower-than-Expected Q4 Loss
Dec 06 / Zacks.com - Paid Partner Content
Mallinckrodt (MNK) Tops Q4 Earnings on Solid Sales Growth
Nov 29 / Zacks.com - Paid Partner Content
Novo Nordisk Files Regulatory Application for Semaglutide
Dec 06 / Zacks.com - Paid Partner Content
Amicus Provides Regulatory Update on Fabry Disease Drug
Nov 29 / Zacks.com - Paid Partner Content
Acceleron, Celgene Present Myelodysplastic Syndromes Data
Dec 05 / Zacks.com - Paid Partner Content
AVEO Partner Submits Response to Questions on Tivozanib
Nov 29 / Zacks.com - Paid Partner Content
Alnylam Reports Positive Data on Fitusiran, Givosiran
Dec 05 / Zacks.com - Paid Partner Content
Nivalis (NVLS) Cystic Fibrosis Study Misses Primary Endpoint
Nov 29 / Zacks.com - Paid Partner Content
Pfizer (PFE) Presents Favorable Data on Leukemia Candidate
Dec 05 / Zacks.com - Paid Partner Content
Glaxo (GSK) Files Regulatory Application for Shingrix in EU
Nov 28 / Zacks.com - Paid Partner Content
Incyte Jakafi Positive in Pooled Analysis of Five-Year Data
Dec 05 / Zacks.com - Paid Partner Content
Eli Lilly Hits 52-Week Low on Poor Data on Alzheimer's Drug
Nov 25 / Zacks.com - Paid Partner Content
Alexion Presents Data from Ultra-Rare Blood Disorder Study
Dec 05 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: Electronic Arts, Vanda Pharmaceuticals, Advanced Energ...
Nov 25 / Zacks.com - Paid Partner Content
Pfizer Offers Positive Phase III Data on Pediatric Epilesy Drug
Dec 02 / Zacks.com - Paid Partner Content
Merck's New Drugs, Cost Management to Fuel Growth in 2017
Nov 25 / Zacks.com - Paid Partner Content
bluebird Stock Up on Positive Interim Multiple Myeloma Data
Dec 02 / Zacks.com - Paid Partner Content
Glaxo Nucala Favorable in Rare Vasculitis Disease Study
Nov 24 / Zacks.com - Paid Partner Content
Merck KGaA (MKGAF) Expands Distribution Deal with Roche
Dec 02 / Zacks.com - Paid Partner Content
Buy These 5 Efficient Stocks for Thanksgiving
Nov 23 / Zacks.com - Paid Partner Content
AbbVie Crohn's Disease Drug Gets Orphan Drug Status in U.S.
Dec 01 / Zacks.com - Paid Partner Content
Galapagos (GLPG) Filgotinib in Phase III for Crohn's Disease
Nov 23 / Zacks.com - Paid Partner Content
Heat Biologics Stock Falls on Negative Bladder Cancer Data
Dec 01 / Zacks.com - Paid Partner Content
Allergan Acquires Chase Pharma, Expands CNS Portfolio
Nov 23 / Zacks.com - Paid Partner Content
Ultragenyx (RARE) Reports Positive Phase II Study on UX007
Dec 01 / Zacks.com - Paid Partner Content
Oragenics Jumps on Fast Track Status for Oral Mucositis Drug
Nov 23 / Zacks.com - Paid Partner Content
Agenus' INCAGN1876 in Phase I/II Study for Solid Tumors
Dec 01 / Zacks.com - Paid Partner Content
Bristol-Myers' Opdivo Gets EU Approval for Label Expansion
Nov 23 / Zacks.com - Paid Partner Content